Skip to content

Clinical trials

Terminated Myelodysplastic Syndromes trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Terminated Country / region: Belgium Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20101
20111
20141
20151
20164
20171
20181
20191
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Incyte Corporation2
Kiadis Pharma2
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
Hemavant Sciences GmbH1
Janssen Research & Development, LLC1
Kyntra Bio1
Syros Pharmaceuticals1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes17
Leukemia, Myeloid, Acute5
Multiple Myeloma4
Myeloproliferative Disorders4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Neoplasms3
Leukemia, Myelomonocytic, Chronic3
Lymphoma3
Lymphoma, Non-Hodgkin3
Primary Myelofibrosis3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.